在接受阿托伐醌预防治疗的免疫功能低下患者中检测到具有多重耐药突变的变体。
Variant With Multiple Resistance Mutations Detected in an Immunocompromised Patient Receiving Atovaquone Prophylaxis.
作者信息
Holbrook Nolan R, Klontz Erik H, Adams Gordon C, Schnittman Samuel R, Issa Nicolas C, Bond Sheila A, Branda John A, Lemieux Jacob E
机构信息
Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
出版信息
Open Forum Infect Dis. 2023 Feb 23;10(3):ofad097. doi: 10.1093/ofid/ofad097. eCollection 2023 Mar.
We report genomic sequences with multiple mutations in the atovaquone-target region of cytochrome b, including a newly identified Y272S mutation, plus 1 mutation of undetermined significance in the azithromycin-associated ribosomal protein L4. The parasite was sequenced from an immunocompromised patient on prophylactic atovaquone for pneumonia before diagnosis of babesiosis.
我们报告了细胞色素b的阿托伐醌靶区存在多个突变的基因组序列，包括一个新发现的Y272S突变，以及阿奇霉素相关核糖体蛋白L4中一个意义未明的突变。该寄生虫是从一名免疫功能低下的患者身上测序得到的，该患者在诊断巴贝斯虫病之前因预防肺炎而服用阿托伐醌。
Zotero 插件